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Background: Cocoa pod is an outer part of cocoa fruits being discarded during cocoa bean processing. Authors
found out that data on its usage in literature as cosmetic materials was not recorded in vast. In this study, cocoa
pod extract was investigated for its potential as a cosmetic ingredient.
Methods: Cocoa pod extract (CPE) composition was accomplished using UHPLC. The antioxidant capacity were
measured using scavenging assay of 1,2-diphenyl-2-picrylhydrazyl (DPPH), β-carotene bleaching assay (BCB) and
ferric reducing antioxidant power (FRAP). Inhibiting effect on skin degradation enzymes was carried out using
elastase and collagenase assays. The skin whitening effect of CPE was determined based on mushroom tyrosinase
assay and sun screening effect (UV-absorbance at 200-400 nm wavelength).
Results: LC-MS/MS data showed the presence of carboxylic acid, phenolic acid, fatty acid, flavonoids (flavonol and
flavones), stilbenoids and terpenoids in CPE. Results for antioxidant activity exhibited that CPE possessed good
antioxidant activity, based on the mechanism of the assays compared with ascorbic acid (AA) and standardized
pine bark extract (PBE); DPPH: AA > CPE > PBE; FRAP: PBE > CPE > AA; and BCB: BHT > CPE > PBE. Cocoa pod extract
showed better action against elastase and collagenase enzymes in comparison with PBE and AA. Higher inhibition
towards tyrosinase enzyme was exhibited by CPE than kojic acid and AA, although lower than PBE. CPE induced
proliferation when tested on human fibroblast cell at low concentration. CPE also exhibited a potential as UVB
sunscreen despite its low performance as a UVA sunscreen agent.
Conclusions: Therefore, the CPE has high potential as a cosmetic ingredient due to its anti-wrinkle, skin whitening,
and sunscreen effects.
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Skin wrinkles form as a result of natural aging process
and the presence of excessive amount of reactive oxygen
species (ROS) [1]. Although skin has self-defence system
to deal with ROS, excessive and chronic exposure to UV
can overwhelm the condition leading to oxidative stress
and damage resulting premature aging. An imbalance of* Correspondence: azrinaaz@upm.edu.my
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article, unless otherwise stated.ROS on skin is due to factors such as overexposure to
sunlight [2] and lack of essential nutrient intake [3]. In
normal condition, skin produces enzymes such elastase
and collagenase, at similar rate as aging process occurs
and age increases. However, with overexposure to sun-
light (UVA and UVB), the presence of excessive ROS
and smoking habit [4], the enzymes are produced at a
faster rate resulting in faster degradation of elastin and
collagen which are the main foundation of extracellular
matrix (ECM) of the dermis [5]. Additionally, excessive
exposure to sunlight, induced production of melanin in
the skin layer. Tyrosinase is the responsible enzyme that
initiates skin pigmentation [6]. Potentially, plant extractsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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by encountering the ROS [3] and protecting the skin
from UV [1]. The extracts protect the skin in various
ways, including scavenging the ROS, reducing the ROS
reactivity, inhibiting the oxidation, absorbing the UV
light, suppressing the enzymes, thus reducing the risk of
wrinkle formation and protecting the skin from aging.
Examples of compounds that have attracted researchers
to topical skin applications are polyphenols, triterpenes
and stillbenoids. Polyphenols have a phenol ring with at
least one hydroxyl substituent that enables scavenging of
ROS, reducing metal ions, modulating protein phos-
phorylation (related to inhibition of enzymes activity),
and inhibiting lipid peroxidation [8].
Cocoa pods are agricultural waste abundantly produced
in cocoa plantations during the extraction of cocoa beans
for cocoa processing. As discarded materials, cocoa pods
can initiate the black pod disease by making the ground
susceptible to the growth of fungi, which is typical in hot
and humid climate. The pods vary in color (from maroon
to green) and thickness when ripe depending on their
clone. In Malaysia, multi clones of cocoa are planted and
when discarded, the pods are thrown away in bulk regard-
less of the clones. Cocoa pods are used as fertilizers and
animal feed. It is also being used as a source of activated
carbon (unpublished data), potash, colorant [9], gum [10]
and anti hypercholesterolemia supplement [11]. Previously,
total phenolic content of cocoa pod husk was determined
at 45.6-46.4 mg gallic acid equivalent of soluble phenolic
while 32.3% carbohydrate, 21.44% lignin, 19.2% sugars,
8.6% protein and 27.7% minerals were reported [12].
Higher level of antioxidant in cocoa pod extract by total
phenolic content (TPC) was reported at 49.54 ± 3.39 mg
gallic acid equivalent (GAE) per gram sample and total fla-
vonoid content (TFC) at 22.42 + 0.98 mg rutin equivalent
per gram sample (unpublished data). Sartini et al. [11] also
reported higher TPC value of cocoa pod husk at 56.5 ±
0.57 mg GAE/g. Scientific publication on identification of
polyphenol compounds in a cocoa pod is rare, necessitat-
ing further research. Therefore, the present experiment
was carried out to determine the cocoa pods compounds,
which are rich in antioxidant activity and can be turned
into high end-value products. In this paper, we investi-
gated the anti-wrinkle, skin whitening and potential
UV-protecting properties of cocoa pod extract using in-
vitro assays and identified the potential of this extract
as a new active ingredient for cosmetic.
Methods
Reagents
Reagents used were of analytical grade purchased from
suppliers such as Sigma-Aldrich for 1,2-diphenyl-2-
picrylhydrazyl (DPPH), L-(+)-ascorbic acid (AA), Lino-
leic acid, Kojic acid (KA), Tyrosinase (from mushroom)and L-3,4-dihydroxyphenyl-alanine methyl ester hydro-
chloride (L-DOPA); Merck for acetonitrile, ammonium
formate, formic acid, dimethylsulfoxide (DMSO), hydro-
chloric acid (HCl), chloroform and Tween-20; Fluka for
2,4,6-tripyridyl-s-triazine (TPTZ); Qrec for ferric chloride
(FeCl3), Friendemann Schmidt for ferrous sulfate (FeS-
O4.7H2O), GmbH for ethanol and methanol; and MP Bio-
medicals for β-carotene powder. Test kits purchased from
Enzo Life Sciences, Inc. Standardized Pine Bark extract
(PBE) sample was provided by DKSH Malaysia Sdn Bhd
(sample from Horphag, Switzerland) and used as a positive
control in addition to ascorbic acid, and butylated hy-
droxytoluene (BHT, Sigma-Aldrich) in β-carotene bleach-
ing assay. Human dermal fibroblast, adult (HDFa) was
acquired from Life Technologies Corporation (GIBCO,
catalogue number C-013-5C; Lot number 1378119) as well
as Dulbecco’s modified Eagle’s medium (DMEM) and
Trypsin (Trypsin LE™). Fetal bovine serum (FBS) and
Streptomycin/Penicillin (antibiotics) obtained from Bio-
west. MTT or 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide supplied by Bio Basic Canada Inc.
Phosphate Buffer Saline (PBS, 10X) purchased from R&M
Chemicals, UK.
Sample preparation
Discarded cocoa pods collected from a cocoa fermenta-
tion site at cocoa plantation in Cocoa Development and
Research Centre, Jengka, Pahang, Malaysia. After rinsed
with tap water, the pods were chopped using mechanical
fruit slicer (FC-312, Zhaoqing Fengxiang Food Machinery,
China) for better water removal when drying in high-
performance dryer (FD-825, Protech, Malaysia). The dried
pods were ground into powder at 1.0 mm size using a
grinding machine with a sieve (Automatic Hammer Mill
Grinder, China). The cocoa pod powder was kept in tight
containers at room temperature (not more than two
weeks) until extraction procedure adjourned.
Twenty millilitres of aqueous ethanol (80%) were poured
into a conical flask containing one gram of cocoa pod
powder and shaken in water bath shaker (BS-21, Lab
Companion, Korea) at 120 rpm, 40°C, for 30 minutes to
prepare the extract. Soluble portion filtered (using Whatt-
man No.1), evaporated to dryness (using vacuum rotary
evaporator; IKA, Germany) and re-dissolved with 5 ml
ethanol after recording the weight. Insoluble material was
filtered out using filter paper. The extracted sample was
stored in air-tight vial at −10°C until evaluated. We used
AA and PBE as the positive control in the study, due to its
effective role in maintaining cellular function [13,14] which
affects the skin condition.
Identification of CPE compound using LC/MS/MS
LC-MS/MS analysis was performed using a Perkin Elmer
Flexar FX-15 ultra-high performance liquid chromatography
Abdul Karim et al. BMC Complementary and Alternative Medicine 2014, 14:381 Page 3 of 13
http://www.biomedcentral.com/1472-6882/14/381(Perkin Elmer, USA). It equipped with a reversed-phase
C18 analytical column of 50 mm × 2.1 mm × 1.9 μm
particle size (Perkin Elmer, USA). The column oven
temperature was set at 35°C, and the flow rate was
250 μl/min. Mobile phases A and B were water and
acetonitrile, respectively, each containing 5 mM ammo-
nium formate and 0.1% formic acid. The linear gradient
programme was set as follows: 0–0.1 min, 90% A/10%
B; 0.1-8 min, 10% A/90% B; 8–10 min, 10% A/90% B;
10–15 min, 90% A/10% B. The injection volume was
20 μL with a run time of 15 minutes. The UHPLC was
hyphenated to a triple quadrupole mass spectrometer
3200 QTrap (ABSciex) equipped with an electrospray
ionization interface set at negative mode. The interface
heater held at the temperature of 500°C and an ion-spray
(IS) voltage of −4500 eV. The nebulising gas (GS1), heating
gas (GS2) and curtain gas pressures set at 40, 40 and
10 psi, respectively during the whole analysis. Nitrogen
was used as collision and spray gas. Full scan data acquisi-
tion was performed, scanning from m/z 5 to 1500 in en-
hanced MS IDA EPI mode. Analyst software version 1.5.2
was used for method development, data acquisition and
data processing.
Determination of antioxidant activities
Antioxidant activities were evaluated using three differ-
ent assays; i.e., 1,2-diphenyl-2-picrylhydrazyl (DPPH),
Ferric Reducing Antioxidant Power (FRAP) and β-
carotene bleaching assay (BCB). Methods of preparation
of DPPH [2,15,16], FRAP [17-22] and BCB [23] solutions
and calculation were adopted with some modifications.
Briefly, DPPH solution was prepared by diluting 1.2 ml of
DPPH stock solution (0.2 M DPPH in ethanol) with 3 ml
ethanol and 0.5 ml DMSO. In a 96-well microplate, 270 μl
of the solution was added to 30 μl of tested sample in a di-
lution series of 7.8-1000 μg/ml, and absorbance measured
at 550 nm [24]. Scavenging effect was calculated by the per-
centage of faded purple DPPH solution color into yellow by
the tested sample against the control (DPPH solution only).
The EC50 of DPPH assay represents the concentration of
the tested sample needed to reduce the DPPH by 50%
where the value obtained from linear regression graph.
For FRAP assay, two solutions; i.e., ferric chloride so-
lution (3 mM in 5 mM citric acid) and TPTZ solution
(2,4,6-tripyridyl-s-triazine; 1 mM in 0.05 M hydrochloric
acid) were prepared. Fifteen μl of the tested sample was
added to 270 μl TPTZ solution and measurement at
620 nm was carried out immediately after addition of
15 μl of ferric chloride solution. The absorbance data
calculated against serial dilution of Ferrous sulfate
(FeSO4.7H2O) and recorded as equivalent to μM Fe
2+.
Effective concentration at 50% (EC50) of FRAP value is
the sample concentration required to reduce 0.5 mol of
Fe3+ to Fe2+.Two milligrams of β-carotene powder was dissolved in
0.2 ml chloroform followed by adding 0.2 ml linoleic
acid, 2 ml Tween20 and 100 ml of distilled water to
make β-carotene solution. It was mixed until almost
transparent solution obtained. Two hundred μl of the
solution was added to 20 μl of the tested solution and
measurement at 450 nm was carried out after incubation
for 20 minutes at 50°C. Measurement was monitored for
2 hours at 30-minute intervals. Calculation of antioxi-
dant activity percentage obtained by the difference of
degradation rate of tested sample to the degradation rate
of control (β-carotene solution only). Effective concen-
tration at 50% (EC50) was determined to represent the
ability of the sample to protect the β-carotene solution
from degradation, thus indicating high antioxidant activ-
ity with low concentration of the tested sample. Instead
of AA, BHT was used as a positive control in this assay.
BHT is well-known antioxidant specifically in protecting
lipid oxidation [25] and stronger antioxidant compound
compared with AA [26].
Determination of elastase and collagenase inhibition
Elastase and collagenase inhibition measurements were
carried out using drug discovery kits (Neutrophil Elastase
Colorimetric and MMP-1 Colorimetric, respectively)
following protocols as in Enzo Life Science [27,28].
For elastase inhibition assay, 20 μl of tested sample
was diluted with 65 μl buffer-solution containing
100 mM HEPES, 500 mM NaCl and 0.05% Tween20
in DMSO in a 96-well plate. Elastatinal (100 μM)
used as the control inhibitor. The neutrophil elastase
enzyme (purified human neutrophil elastase, 2.2 μU/μl) at
10 μl was added to the diluted tested sample and incubated
for 10 minutes at 37°C. Later, 5 μl substrate (MeOSuc-
Ala-Ala-Pro-Val-pNA, 100 μM) was added to each
well and absorbance at 405 nm was monitored for
10 minutes.
Briefly for collagenase inhibition assay, 20 μl of tested
sample was diluted with 50 μl buffer-solution (50 mM
HEPES, 10 mM CaCl2, 0.05% Brij-35 and 1 mM DTNB
in DMSO). Twenty microlitres of MMP-1 enzyme (E.coli
recombinant human MMP-1 catalytic domain, 153 mU/
μl) was added to each well prior to incubation at 37°C
for 30 minutes. Control inhibitor, NNGH (N-Isobutyl-N-
(4-methoxyphenylsulfonyl) glycylhydroxamic acid; 1.3 μM),
was used for comparison. Substrate (thiopeptide, Ac-PLG-
[2-mercapto-4-methyl-pentanoyl]-LG-OC2H5; 100 μM) at
10 μl was added to each well and absorbance at 410 nm
was monitored for 10 minutes.
For both protocols, slope of remaining activity for the
tested sample against the control (without sample) was
calculated in percentage and inhibition percentage was
obtained by subtracting the obtained value from 100. In-
hibition concentration of 50% (IC50) is the concentration
Table 1 Product ion of cocoa pod extract in negative mode
Class Compound Retention time,
tR (min)
m/z Reference in PBE
Sugar Gluconic acid sodium
salt/glucose acid
0.787 195,177,129,85,75 34,35 Yes
Carboxylic acid Tartaric acid 1.184 149,105,87,73 34 No
Flavonoid/flavonol Rhamnetin 1.315 315,241,139,108,97,80,70 34 No
Carboxylic acid Citric acid 1.447 191,111,87 53,35 Yes
Phenolic acid Protocatechuic acid 1.842 153,109,65 38,39 Yes
Phenolic acid Protocathecuic
derivatives/nucleotide
1.972 329,241,199,108,97,69 41/35 No
Phenolic acid Protocathecuic
derivatives/nucleotide
1.974 329,241,139,97,80 41/35 No
Unknown 2.106 330,241,122,96,80 - No
Phenolic acid p-hydroxybenzoic acid 2.238 137,93 36,40 Yes
Phenolic acid Salicyclic acid 2.238 137,108,91,65 35 Yes
Unknown 2.500 363,241,122,96,59 - No
Phenolic acid Methyl salicylate 2.633 151,139,124,91,65 35 No
Nucleotide disodium salt, nucleotide 2.763 401,327,69 35 No
Phospholipid Phospholipid derivatives 2.897 381,249,161,113,98,85,68 35 No
Glucosinolate Glucosinolate derivatives 3.029 379,155,59 35 No
Flavonoid Sineginhomoorientin derivatives 3.161 355,225,207,96,69,59 35,42 No
Unknown 3.292 358,245,222,178,161,135,123 - No
Unknown 3.293 358,222,178,161,151,135,123 - Yes
Unknown 3.423 452,408,372,328,285,250,230,190,178,160,148,135 - No
Flavones-Sugar Apigenin-c-glucose-c-pentoside 3.425 563,545,473,443,395,383,365,353,325,311,297,233 43 No
Unknown 3.557 357,241,139,96 - No
Glucosinolate Glucosinolate derivatives 3.688 372.2,285.1,136,178,147,160.2,135 35 No
Glucosinolate Glucosinolate derivatives 3.822 439.2,314,300.1,269.1,180.1,151.1,96.9,80.1 35,42 No
Glucosinolate Glucosinolate derivatives 4.086 371,281,241,151,96 35 No
Terpenoid Terpenoid derivatives 4.351 345,201,171,155,59 35 No
Flavonoid/Flavonol Kaempferol derivatives 4.879 723,677,659,550,451,367,225 34 Yes
Terpenoid Terpenoid derivatives 5.010 345,99,59 35 No
Flavonoid Flavone derivatives 5.143 327,309,197 35 No
Unknown 5.404 329,229,211,171,139,99 - No
Flavone Flavone/luteolin 5.407 329,311,229,211,171,139,127,99,69 44 No
Flavonoid Flavone derivatives 5.535 327,205,183,171,69,59 35 No
Ketone-Sugar Ribulose1,5-bisphosphate 5.667 309,265,209,193,151,137,109 53 No
Terpenoid Crysoplenol 5.802 330,172 35 No
Flavonoid Flavones derivatives 6.199 305,287,249,163,135,93 37,54,45,46 No
Flavones-Sugar apigenin glycoside 6.594 313,295,183,171,129,99,58 34,44 No
Phenylpropanoid Chlorogenic acid derivatives 6.858 353,97,80 34 No
Unknown 7.377 339,239,183,170,99 - Yes
Flavonoid Flavones derivatives 7.384 295,277,181,171 35 No
Flavonoid Flavones derivatives 7.516 293,249,195,113 35 No
Flavonoid Flavones derivatives 7.516 293,249,236,220,205,190,177,164,148,81 35 No
Carboxylic acid Malic acid 8.042 133, 115,71 34,47,48,49,53,35 Yes
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Table 1 Product ion of cocoa pod extract in negative mode (Continued)
Stillbenoids Resveratrol 8.567 277 50 No
Stillbenoids Resveratrol 8.567 227 37,51 No
Fatty acid Linoleic acid 9.094 279 41 No
Vitamin Flavin mononucleotide 9.218 455 43 No
Fatty acid Oleic acid 9.620 281 41 No
Flavonoid/flavone Linarin/acacetin 14.350 283 52 Yes
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ities to 50%.
Determination of skin whitening and potential UV-sunscreen
activities
Skin whitening effect was evaluated based on inhibition of
mushroom tyrosinase by the tested sample with L-DOPA
as substrate using a method described by Chiari et al. [29].
The tested solution was diluted in series (1000-250 μg/ml)
using DMSO and 20 μl was pipetted into a 96-well mi-
croplate, followed by addition of 138 μl PBS (phosphate
buffer solution) and 2 μl mushroom tyrosine solution
(2500 U/ml, in PBS). After incubation at 37°C for 90 mi-
nutes, 40 μl of L-DOPA (2.5 mM in PBS) was added,
and measurement at 450 nm monitored for 20 minutes.
Kojic acid was used for comparison.
For UV sunscreen potential activity, the tested sample
was dissolved in ethanol (ratio 8:125). Same solvent wasTable 2 Extra compound of pine bark in negative mode
Class Compound Retention tim
Unknown 1.314
Phenolic acid Gallic acid 1.446
Phenolic acid Methyl benzoate acid/ caffeic acid 1.841











Carboxylic acid Gibbrellin derivatives 5.821
Unknown 6.085
Flavonoid Flavonol derivatives 7.008
Fatty acid Decanoic acid 8.325
Phenolic acid Caffeic acid 13.980used as blank for baseline correction so that the results ob-
tained could be compared with each other. Samples were
scanned at 200-400 nm wavelength using dual beam UV-
Spectrophotometer (Cary 60, US). Absorbance of tested
samples at critical wavelengths (290, 308, 330 and 350 nm)
[30] were selected for comparison. Higher value of absorb-
ance indicates better potential as UV-sunscreen agent, in-
vitro. Two broad spectrums of commercial sunscreens; i.e.
Avobenzone and Octylmethoxycinnamate (OMC) were
used for comparison. The results obtained were only for
screening purposes; therefore, a subsequent experimental
study using non-invasive method had to be carried out to
determine the Sun Protecting Factor (SPF) value prior to
using the extracts in formulation.
Cell viability using human dermal fibroblast
Healthy cells were initiated from cryopreserved HDFa in




















Table 3 Antioxidant activities of CPE, AA and PBE based on (a) Scavenging effect using DPPH assay (b) Metal reducing ion capability, and (c) Antioxidant
activity using β-carotene bleaching assay
Assay Sample Concentration, μg/ml EC50
7.8 15.6 31.3 62.5 125 250 500 1000
(a) DPPH assay (%) AA 45.03 ± 1.74aα 50.14 ± 3.20aβ 63.05 ± 6.39aγ 66.63 ± 1.75bγ 72.21 ± 2.21bδ 73.45 ± 2.24bδ 76.48 ± 2.58bδ 77.53 ± 2.67bδ 13.25
PBE 13.70 ± 0.27bα 23.92 ± 1.04cβ 38.49 ± 2.26bγ 58.89 ± 3.16cδ 67.43 ± 1.71cε 69.93 ± 1.91bε 73.54 ± 1.85bε 74.86 ± 1.42bε 49.33
CPE 10.80 ± 0.63cα 32.10 ± 0.40bβ 58.98 ± 5.82aγ 87.07 ± 3.09aδ 85.01 ± 4.44aδ 86.81 ± 3.47aδ 84.52 ± 3.23aδ 83.28 ± 0.66aδ 26.10
(b) FRAP assay (μM Fe2+) AA 416.24 ± 78.22abαβ 610.43 ± 3.99aγδ 405.47 ± 42.79bαβ 454.19 ± 31.55cβ 336.24 ± 45.33cα 534.53 ± 29.57bγ 599.83 ± 100.81bγ 754.02 ± 72.49aγε 204.25
PBE 398.11 ± 15.95bα 485.06 ± 39.38bβγ 483.67 ± 53.55aβγ 509.22 ± 46.27bγ 551.44 ± 45.71aγδ 435.61 ± 57.16cβγ 793.94 ± 41.84aε 587.83 ± 4.71bδ 70.76
CPE 478.12 ± 46.06aβ 567.86 ± 38.07aγ 390.94 ± 15.23bα 684.27 ± 18.72aδε 526.66 ± 42.06aβγ 620.68 ± 9.07aδ 638.80 ± 52.31bδ 729.57 ± 57.20aε 97.30
(c) BCB assay (%) BHT 31.01 ± 3.60aα 46.83 ± 3.18aβ 59.26 ± 1.46aγ 78.70 ± 3.16aδ 91.72 ± 2.51aε 98.23 ± 6.09aε 97.17 ± 2.82aε 99.17 ± 5.48aε 24.09
PBE 3.67 ± 0.27cα 12.88 ± 2.26bβ 23.20 ± 7.65bγ 25.31 ± 6.89cγ 40.71 ± 8.66cγδ 48.32 ± 7.73cδ 49.59 ± 3.51cδ 63.68 ± 13.15cδ 302.71
CPE 9.65 ± 1.99bβ 5.15 ± 1.10cα 5.74 ± 1.48cα 51.47 ± 5.64bγ 70.50 ± 0.43bδ 81.55 ± 1.08bε 83.44 ± 0.80b£ 88.08 ± 2.73b€ 84.67
a b c dDifferent alphabet in column means significantly different within sample for each assay.

























Table 4 Elastase inhibition activity with elastatinal at
100 μM for positive control inhibitor for CPE, AA and PBE
Sample Concentration (μg/ml) IC50
10 100 500
Elastatinal, 100 μM 30.94 ± 1.47b -
AA 36.02 ± 1.83aβ 27.51 ± 2.59bα - 232.29
PBE 8.57 ± 0.63dα 34.96 ± 1.47aβ 43.28 ± 0.05aγ 31.93
CPE 15.57 ± 0.86cβ 23.47 ± 2.15bγ 2.54 ± 0.04cα 3.51
a b c dDifferent alphabet in column means significantly different within sample.
α β γ δ ε € £different symbol means significantly different within concentration
for each sample in row.
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37°C, 95% humidity and 5% CO2 until confluent. The
growth media was refreshed every two days until at
least 80% confluence was achieved, and was trypsinized
with Trypsin LE™ to passage for not more than eight
times for cell viability study [31]. The cells were seeded
into a 96-well microplate at density of 1×105 per well
and incubated for 24 hours. Serial dilution of CPE, AA
and PBE were added to the well, respectively, after re-
moval of the spent media and incubated for another
24 hour. Forty microliters (40 μL) of MTT in PBS
(2.5 mg/mL) was added to each well and incubated for
4 hours before the absorbance was measured at 570
with 630 nm as reference wavelength. A hundred
microlitres (100 μL) of DMSO was used to dissolve the
dye crystals [32]. The percentage of cell viability was
calculated based on the optical density of each well
against the control (cell without any treatment). Inhib-
ition concentration of 90% (IC90) is the sample concen-
tration that enables 90% of cells survived after
treatment with the tested sample which metabolized
the MTT salts to formazan [33].
Statistical analysis
The results were presented as mean ± standard deviation
determined in triplicates of two independent samples.
Comparison was made using two samples T-test by
Minitab Software version 14.12.0 (US Inc.). Results were
significantly different when p-value was less than 0.05
(p < 0.05).Table 5 Collagenase inhibition activity of CPE, AA and PBE w
Sample Concentr
7.8 15.6 31.3 62.5
NNGH, 1.3 μM 95.9
AA 31.87 ± 3.40cα 44.06 ± 0.07cβ 48.70 ± 2.92cγ 33.84 ± 1.00
PBE 54.96 ± 6.77bδε€ 50.81 ± 0.90bδ 53.32 ± 0.53bε 54.04 ± 1.48
CPE 53.15 ± 0.95bδ 48.81 ± 2.55bγ 53.23 ± 0.41bδ 50.71 ± 0.31
a b c dDifferent alphabet in column means significantly different within sample.
α β γ δ ε € £different symbol means significantly different within concentration for eaResults and discussion
Identification of CPE compound using LC/MS/MS
Crude CPE was analyzed by LC/MS/MS in negative
mode. We identified each compound based on the litera-
ture search in established spectrum databases [34,35].
Product ion spectrum of CPE was compared with the
product ion spectrum obtained from the search and was
listed in Table 1 [34-54] according to its retention time.
We considered the compound as its derivatives, if the
product ion spectrum did not hit any of the product ion
m/z in the search but hit only the first and one or more
of the product ion m/z in the spectrum. PBE, known to
contain a wide range of polyphenol compounds [36],
was also analyzed for comparison purposes. Compounds
that are similarly available in PBE also were noted at the
end column of Table 1. Additionally, compounds that
appear only in PBE were listed in Table 2 [34,35,55-57].
CPE and PBE contained almost similar compounds, in-
cluding polyphenols, carboxylic acid (citric acid and
malic acid) and sugars (gluconic acid sodium salt). Poly-
phenolic compounds in CPE included phenolic acids
(protocatechuic acid, p-hydroxybenzoic acid and salicyc-
lic acid), flavonols (kaempferol) and flavones (linarin),
which also were detected in PBE. Resveratrol, a stilbe-
noids compound that was detected in wine [37], was also
found in CPE but not in PBE. CPE also was detected
with tartaric acid, apigenin and luteoin (flavone), cryso-
plenol (terpenoids), linoleic acid and oleic acid (fatty
acids) which were not available in PBE. Nevertheless,
gallic acid, catechin [58], quercetin and caffeic acid were
found in PBE but were absent in CPE.
Antioxidant activities
Absorbance at 550 nm of cocoa pod extract was mea-
sured after at least 10 minutes of incubation at room
temperature by DPPH assay to ensure complete reac-
tion. The incubation time was determined previously
(data not included) by a method as described by
Marxen et al. [24]. CPE achieved optimum value of
scavenging percentage by this assay at 62.5 μg/ml,
which was lower than PBE and AA at 125 μg/ml
(Table 3). At this optimum value, CPE showed significantly
higher antioxidant activity (87.07 ± 3.09%; 62.5 μg/ml)ith NNGH at 1.3 μM for positive control inhibitor
ation (μg/ml) IC50
125 250 500 1000
1 ± 0.23a -
dα 31.70 ± 2.36cα 61.75 ± 8.51bcδ 52.91 ± 4.24aγ 90.16 ± 1.27aε 261.38
bε 16.79 ± 2.27dα 60.56 ± 4.98c€ 46.00 ± 1.64bγ 39.26 ± 3.98cβ 356.01
cγ 38.53 ± 4.22bβ 68.71 ± 2.12bε 29.97 ± 1.36cα 71.44 ± 2.28bε 111.29
ch sample in row.
Table 6 Skin whitening activity (%) of CPE, AA and PBE using mushroom tyrosinase against kojic acid (KA)
Sample Concentration, μg/ml IC50
7.8 15.6 31.3 62.5 125 250 500 1000
KA 18.07 ± 0.25bβ 22.44 ± 0.04bγ 11.17 ± 1.71cα 11.71 ± 1.27cα 24.12 ± 4.89bγ 52.22 ± 7.46bδ 47.78 ± 4.07bδ 68.80 ± 2.89cε 572.28
AA 8.29 ± 0.81cβ 7.25 ± 0.08cα 14.15 ± 2.88bγδε 13.51 ± 1.40c δ 11.84 ± 0.47cγ 25.26 ± 0.89d 18.61 ± 2.71cε 29.62 ± 1.51d€ 670.82
PBE 42.57 ± 1.98aβγ 41.22 ± 2.21aβ 43.14 ± 2.78aβγ 44.16 ± 0.79aγ 48.31 ± 2.71aδ 36.67 ± 0.40c α 49.10 ± 2.97bδ 77.65 ± 4.51bε 315.16
CPE 16.17 ± 2.67bα 21.52 ± 2.29bβ 16.97 ± 3.48bαβ 27.78 ± 3.19bγ 41.99 ± 6.93aδ 62.23 ± 0.47aε 65.87 ± 4.20aε 86.51 ± 2.12a € 357.95
a b c dDifferent alphabet in column means significantly different within concentration.
α β γ δ ε € £different symbol means significantly different within concentration for each sample in row.
Abdul Karim et al. BMC Complementary and Alternative Medicine 2014, 14:381 Page 8 of 13
http://www.biomedcentral.com/1472-6882/14/381compared with AA (72.21 ± 2.21%; 125 μg/ml) and PBE
(67.43 ± 1.71%; 125 μg/ml). The effective concentration
to reduce the DPPH radical to 50% (EC50) was deter-
mined by plotting linear regression curve of DPPH ac-
tivity versus ratio of sample concentration to DPPH as
previously reported [24]. The tested sample with EC50
value lower than 30 μg/ml by DPPH assay, has high effi-
ciency as free radical scavenger [2], specifically against
superoxide anion radicals [59], as exhibited by CPE,
which was two times higher antioxidant activity than
standardized PBE, although it indicated a two-fold de-
crease in comparison with AA. The presence of more
than one carboxylic acid such as citric acid and malic
acid, besides phenolic acid and other polyphenols in
CPE is suggested to contribute to high antioxidant
value by DPPH assay [59], compared with AA, which
contained a single compound. In addition, higher anti-
oxidant activity values by DPPH assay for CPE than
PBE is also attributed to the presence of terpenoid and
resveratrol compounds.
The ability of the tested solution to deviate the mech-
anism of Fenton reaction by chelating the metal ions
[60], such as Fe2+ and Cu2+, which is responsible to con-
vert the hydrogen peroxide to hydroxyl radical (ROS) on
the skin [6], can be measured using FRAP assay. We
conducted a kinetic study for the tested sample at
620 nm (data not published) measured after five minutes
of reaction. CPE had similar antioxidant activity to AA
when measured using FRAP assay except at 250 μg/ml,
where the FRAP value of CPE was significantly higher
than AA and PBE. Antioxidant activity of PBE wasTable 7 Absorbance of CPE at critical wavelength in comparis
pine bark extract
Sample
290 (UVB) 308 (UV
Avobenzone 2.080 ± 0.033c 1.926 ± 0
OMC 2.145 ± 0.002b 2.126 ± 0
PBE 0.589 ± 0.009d 0.231 ± 0
CPE 2.639 ± 0.010a 2.130 ± 0
a b c dDifferent alphabet in column means significantly different within sample at eaproportional to the tested concentration and showed sig-
nificantly higher activity when compared with EC50
value of the FRAP assay. Although CPE had three times
higher metal reducing ion potential than AA, its per-
formance was 1.4 times lower than that of PBE. The
presence of chlorogenic acid derivatives in CPE is likely
to contribute to its higher FRAP value than that of AA
since this compound is metal chelating ion [60]. Other
than that, flavonol derivatives are also known to chelate
metal ions [25], such as rhamnetin and kaempferol deriva-
tives in CPE. Flavanol compounds, such as catechin and
quercetin also contribute to the chelating action on metal
ion [26], which are available in PBE but absent in CPE,
resulting in higher FRAP value for PBE. Phenolics with ion
reducing ability diminish the possibility of hydroxyl radi-
cal’s formation path from superoxide anion radicals and
additionally inhibit enzymes due to their abilities to chelate
copper at the active site [6].
β-carotene in BCB assay serves as an indicator that de-
grades during the oxidation process when linoleic acid
turns to hydroperoxides at high incubation temperature
[61]. The presence of antioxidant eliminates or reduces
the action of this radical species to β-carotene as mea-
sured by the absorbance at 450 nm and calculation of
degradation rate. High value of antioxidant activity by
BCB assay exhibits the tested solution is a good antioxi-
dant agent due to the presence of linoleic acid that acts
as pro-oxidant [21]. CPE achieved optimum value of
antioxidant activity at concentration of 250 μg/ml
(81.55 ± 1.08%), which was higher than standardized PBE
and BHT at 125 μg/ml (40.71 ± 8.66% and 91.72 ± 2.51%,on with commercial sunscreen agents and standardized
Wavelength (nm)
B) 330 (UVA) 350 (UVA)
.052b 2.519 ± 0.091a 2.723 ± 0.247a
.030a 2.413 ± 0.124a 2.796 ± 0.145a
.005c 0.126 ± 0.003c 0.063 ± 0.002c























Figure 1 Absorbance of tested samples compared with
commercial UV-sunscreen agent (Avobenzone and
Octylmethoxycinnamate) at 200–400 wavelength.
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activity than BHT, but based on EC50 value; antioxidant
activity of CPE was four times lower than that of BHT
while PBE showed the lowest activity. Higher antioxidant
activity of CPE in comparison with PBE can be attributed
to the terpenoid and resveratrol compounds that solely in-
dicate better protection for lipid oxidation [62,63]. Plant
extracts with lipid protection properties can protect the
skin from lipid peroxyl radicals that attack stratum cor-
neum layer [63].
Elastase and collagenase inhibition
Determination of elastase inhibition at higher concentra-
tion (1000 μg/ml) of CPE and standardized PBE resulted
in a negative slope, which was also observed for 500 μg/
ml of AA, indicating no activity of elastase either for in-
hibition or activation. This situation should be taken
into consideration to avoid false positive results, where
the inhibition detects at certain concentration range of
extracts or control inhibitors; i.e. elastatinal (100 μM) as
in Enzo Life Science Manual [27] as well as the concen-
tration of enzyme (neutrophil elastase enzyme, 100 μM)
used in this study. Table 4 summarizes the result of elas-
tase inhibition for CPE and standardized PBE at concen-
trations of 500, 100 and 10 μg/ml. At high concentrations
(500 and 100 μg/ml), standardized PBE exhibited higher
activity than control inhibitor, which was in agreement
with a previous report by Grimm et al. [64]. Catechin, a
flavanol was reported to have an inhibitory effect on elas-
tase enzyme [65,66], which is also present in PBE. Catechin
was also reported to inhibit binding activity of transcrip-
tion factors and kinases (AP1 and NF-κB), therefore lower-
ing the activity of MMPs for collagen degradation and
inflammation [67]. CPE has lower elastase inhibition activ-
ity in comparison with standardized PBE at 100 μg/ml but
similar to AA and control inhibitor. Terpenoid compounds
were previously suggested as elastase inhibitors [65], is
present in CPE since flavones and flavonol componentsare not efficient inhibitors of elastase activity [66]. The in-
hibition of elastase by CPE was much lower at lower con-
centration (10 μg/ml) in comparison with AA although
higher than standardized PBE. Therefore, CPE has low ac-
tivity to inhibit the elastase enzyme which is responsible
for degradation of elastin fibrous structure in a dermal
matrix.
CPE exhibited almost two times better collagenase inhi-
bition activity than AA and three times better activity than
standardized PBE based on IC50 (Table 5). Increasing the
concentration of the tested sample to more than
1000 μg/ml (data not shown) did not affect the collage-
nase inhibition activity, as exhibited by standardized
PBE. Research by Lim et al. [68] indicated that ka-
empferol and quercetin were strong inhibitors of colla-
genase while apigenin, a flavone compound, weakly
inhibited collagenase activity. Flavonols had better
inhibition activity towards collagenase enzyme than fla-
vones compounds [69]. Resveratrol, a stilbenoid com-
pound, was patented for its effective inhibition against
the collagenase effectively in reducing wrinkles [70].
CPE showed significantly higher collagenase inhibition
activity than standardized PBE at 1000 μg/ml, although
the activity was lower than that of AA and control in-
hibitor. The higher inhibition by CPE can be attributed
to the presence of more than one flavonol compound,
whereas PBE has only one identified flavonol com-
pound. In addition, CPE was detected with two types of
resveratrol compared with PBE. Therefore, the pres-
ence of various polyphenolic compounds in CPE con-
tributed to its potential in maintaining collagen
longevity in the skin layer [4].
Skin whitening and UV-protecting potential
The capability of CPE to inhibit tyrosinase activity can
be translated to its potential as skin whitening agent.
When tyrosinase enzyme activity is inhibited, melanin
production is reduced, resulting in a fairer skin. Inhib-
ition of tyrosinase activity was significantly higher in
CPE than standardized PBE at high concentration
(1000 μg/ml) but showed similar activity at lower con-
centration (125 μg/ml). CPE was also found to be a bet-
ter inhibitor of tyrosinase activity than kojic acid and
ascorbic acid (Table 6), although not as good as PBE
based on the IC50 value. CPE and PBE contained sev-
eral compounds, such as flavonols, flavanols, stilbe-
noids and phenolic acid, reported to inhibit tyrosinase
activity [6]. Quercetin, a flavonol compound, inhibits
tyrosinase enzyme better than kaempferol [71] suggest-
ing higher inhibition activity by PBE [58] than CPE.
Resveratrol in CPE contributed to the inhibition of the
enzyme; however, this contribution was less than that
of oxyresveratrol [72]. Fatty acids, such as linoleic acid
and oleic acid, which were detected in the CPE too,
Table 8 Cell viability (%) of the CPE against HDFa in comparison with PBE and AA
Sample Concentration, μg/ml IC90
3.9 7.8 15.6 31.3 62.5 125 250 500 1000
AA 14.35 ± 3.04bα 18.70 ± 1.84c α 22.17 ± 0.61c β 36.96 ± 4.30aγ 40.87 ± 3.69cδ 108.26 ± 24.90aε 590.43 ± 19.68a€ 1407.39 ± 46.12a£ 651.30 ± 133.04a€ 57.10
PBE 17.95 ± 1.21bα 24.79 ± 2.42bβ 29.49 ± 1.81bγ 42.31 ± 5.44aδ 69.23 ± 1.21aε 118.35 ± 1.81a€ 202.14 ± 42.91b£ 335.47 ± 17.53bζ 285.47 ± 49.56b£ζ 101.21
CPE 368.47 ± 46.15aγ 62.32 ± 4.49aβ 40.80 ± 7.41aα 39.92 ± 2.74aα 55.62 ± 8.32bβ 58.47 ± 6.26bβ 61.75 ± 11.20cβ 76.83 ± 12.25cβ 62.82 ± 10.11cβ 7.42
a b c dDifferent alphabet in column means significantly different within concentration.
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without adverse effects [73].
Absorbance at UVC spectrum (200-290 nm) is not
discussed as the radiation is filtered by the atmosphere.
Meanwhile, absorbance of the tested samples at the
other two spectrums; i.e., UVB (290-315 nm) and UVA
(315-400 nm), are discussed. There are two ways in
which sunscreen agent in cosmetic products protect
the skin: (i) by scattering the UV-rays (titanium and
zinc oxide) or (ii) by absorbing the light before reach-
ing the skin. Plant extract, especially with flavones [74]
and pigments, can absorb UV light [67]. CPE showed
potentially good UV absorbance at UVB range wave-
length, which was even better than the commercially
used UV-protecting agent in this study; i.e. Avoben-
zone and Octylmethoxycinnamate (OMC), and sig-
nificantly better than standardized PBE at 290 nm
(Table 7). Higher sun-protecting action in CPE could
be caused by flavone derivatives such as luteolin [75] at
UVA wavelength (330 nm), which were absent in PBE.
The presence of methyl salicylate compound in CPE
also enhanced the absorbance [76]. CPE also showed
similar absorbance potential to that of commercial
UV-sunscreen agent, OMC, at 308 nm, the peak of ery-
thema (sunburn) action spectrum [77]. The extract had
significantly better absorbance than Avobenzone at
this wavelength.
CPE had moderate absorbance of UVA (315-400 nm) as
illustrated in Figure 1, which was significantly better than
that of standardized PBE (Table 7). Therefore, CPE has
better potential as UVB sunscreen agent for cosmetic
formulation and can be recommended in combination
with other sunscreen agents with higher UVA absorbance
properties. All plant extracts with pigment and color can
absorb UVA and or UVB [67] as CPE does. Extracts with
color might not be possible for white cream formulation;
however, for color cosmetic products; i.e. foundation
and lipstick, colored extracts could be added as sunscreen
agents.
Cell viability using human dermal fibroblasts
In this study we calculated the IC90, the concentration
of the tested solution to maintain the cell population up
to 90%. High value of IC90 indicated that high concen-
tration of the tested solution is needed to maintain the
population of fibroblast cell. Table 8 shows that CPE had
the lowest value indicating low concentration of the ex-
tract was able to maintain the cell growth at 90%. The
highest value obtained by PBE, which was almost two
times more than that of AA. Almost no toxicity was ex-
hibited by CPE at the tested concentration since the cell
viability percentage was more than 50%, in comparison
with AA and PBE. There could be possible cell death at
low concentrations for AA at 62.5 μg/ml and PBE at31.3 μg/ml, in contrast to the results of a study con-
ducted by Kim et al. [58] in which PBE showed no tox-
icity to B16 melanoma cell, a type of cell different from
the one used in this study. At high concentrations of AA
and PBE, the cells proliferated as shown by the increas-
ing percentage of more than 100%, the highest percent-
age being achieved at 500 μg/ml. Contrary to CPE, at
low concentration of the tested solution (3.9 μg/ml), the
percentage of cell viability was the highest, thus low con-
centration of CPE was needed to induce proliferation of
fibroblast cell.
Conclusions
We concluded that cocoa pod extract exhibits better
antioxidant activities potential than standardized pine
bark extract as measured using DPPH scavenging and β-
carotene bleaching assays, but lower activities using
FRAP assay, based on EC50. CPE inhibited collagenase
and elastase enzymes better than PBE, although second
to PBE in inhibiting the tyrosinase enzyme. Cocoa pod
extract also possesses high potential as UVB sunscreen
agent although with lower performance in UVA range
wavelength than that of the commercial sunscreen agent.
However, the extract can be formulated with other UVA
protecting agents to work synergistically for a broad
spectrum of UV exposure. We, therefore, recommend a
possible use of CPE as ingredient for functional cosmetic
products specifically for anti-wrinkles as well as skin
whitening or sunscreen products in combination with
natural plant extracts to widen the spectrum of protecting
from sun-rays.
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